Adaptive Biotechnologies (ADPT) revealed Loss for fourth quarter of -$33.7 million
The company's bottom line came in at -$33.7 million, or -$0.23 per share. This compares with -$69.4 million, or -$0.48 per share, last year.
The company's revenue for the period rose 3.7% to $47.5 million from $45.8 million last year.
Adaptive Biotechnologies earnings at a glance (GAAP) :
-Earnings: -$33.7 Mln. vs. -$69.4 Mln. last year.
-EPS: -$0.23 vs. -$0.48 last year.
-Revenue: $47.5 Mln vs. $45.8 Mln last year.
For comments and feedback: editorial@rttnews.com